PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Recruiting now · Not applicable

Conditions studied: NSCLC Stage II, NSCLC, Stage III

In brief

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Key facts

Study ID

NCT06945484

Run by

University of Utah

People needed

20

Starts

2025-11-21

Expected to finish

2030-12-01

Last updated by the study team

2026-02-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ages 18 and older at time of diagnosis
• Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
• Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
• Patient able to follow direction and complete questionnaires in English or Spanish
• Patient agrees to complete the PERCC intervention

You may not qualify if…

• Morbidly obese (BMI >40 kg/m2 ) or anorexic (BMI <17.5 kg/m2 )
• Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance
• Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer)
• Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started

Where it is running

• University of Texas Medical Branch at Galveston — Galveston, Texas, United States (enrolling)
• Huntsman Cancer Institute — Salt Lake City, Utah, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.